Experts say patients can get results before they leave the doctor’s office, allowing them to start treatments earlier. Share on Pinterest Researchers say the new chlamydia test is just as accurate as ...

Add Yahoo as a preferred source to see more of our stories on Google. A photomicrograph of Chlamydia trachomatis taken from a urethral scrape. If left untreated, chlamydia can cause severe and costly ...

In the midst of record-high rates of sexually transmitted infections (STIs or STDs), a new industry-sponsored survey finds that many of those at high risk for STDs are not getting tested—and don’t ...

Chlamydia trachomatis infection is the most prevalent sexually transmitted infection worldwide; thus, rapid detection and treatment are crucial to prevent further transmission. Investigators assessed ...

A new urine test developed with funding from the Wellcome Trust will allow doctors to diagnose Chlamydia infection in men within the hour, improving the ability to successfully treat the infection on ...

Credit: Visby Medical. The approval was based on a clinical study that included 2203 females aged 14 years and older. The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s ...

Researchers have successfully completed the clinical trial for a new rapid test for the sexually transmitted infection chlamydia. The researchers believe the test, which is able to detect chlamydia in ...

Please provide your email address to receive an email when new articles are posted on . Compared with urine samples, vaginal swabs had significantly greater sensitivity for chlamydia and gonorrhea.

The US Food and Drug Administration has greenlit the first test for chlamydia and gonorrhea that will allow users to collect samples at home. After HIV, this is the first FDA-authorized test that will ...

Sexually transmitted infections, or STIs, include both sexually transmitted diseases, known as STDs, and the many infections that don’t progress to disease. STIs are caused by more than 30 different ...

The first vaccine against chlamydia has passed its first test in humans. About three dozen healthy women were randomly assigned one of two versions of a chlamydia vaccine or a placebo treatment in a ...